SK282361B6 - Farmaceutický prostriedok na diabetes mellitus - Google Patents

Farmaceutický prostriedok na diabetes mellitus Download PDF

Info

Publication number
SK282361B6
SK282361B6 SK232-2001A SK2322001A SK282361B6 SK 282361 B6 SK282361 B6 SK 282361B6 SK 2322001 A SK2322001 A SK 2322001A SK 282361 B6 SK282361 B6 SK 282361B6
Authority
SK
Slovakia
Prior art keywords
tyr
asn
insulin
glucose
cys
Prior art date
Application number
SK232-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Stefan M�Llner
Wolfgang K�Nig
Gnter Mller
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Publication of SK282361B6 publication Critical patent/SK282361B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK232-2001A 1990-12-19 1991-12-18 Farmaceutický prostriedok na diabetes mellitus SK282361B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4040574 1990-12-19

Publications (1)

Publication Number Publication Date
SK282361B6 true SK282361B6 (sk) 2002-01-07

Family

ID=6420676

Family Applications (2)

Application Number Title Priority Date Filing Date
SK232-2001A SK282361B6 (sk) 1990-12-19 1991-12-18 Farmaceutický prostriedok na diabetes mellitus
SK3879-91A SK282360B6 (sk) 1990-12-19 1991-12-18 Peptidy, spôsob ich výroby, farmaceutický prostriedok tieto látky obsahujúci a ich použitie

Family Applications After (1)

Application Number Title Priority Date Filing Date
SK3879-91A SK282360B6 (sk) 1990-12-19 1991-12-18 Peptidy, spôsob ich výroby, farmaceutický prostriedok tieto látky obsahujúci a ich použitie

Country Status (24)

Country Link
US (1) US5461035A (ja)
EP (1) EP0491361B1 (ja)
JP (2) JP3378588B2 (ja)
KR (1) KR100237948B1 (ja)
AT (1) ATE177753T1 (ja)
AU (1) AU643349B2 (ja)
CA (1) CA2058020C (ja)
CZ (1) CZ284568B6 (ja)
DE (1) DE59109109D1 (ja)
DK (1) DK0491361T3 (ja)
ES (1) ES2130130T3 (ja)
FI (1) FI105816B (ja)
GR (1) GR3030510T3 (ja)
HR (1) HRP940839B1 (ja)
HU (1) HU222493B1 (ja)
IE (1) IE914408A1 (ja)
IL (1) IL100400A (ja)
NO (1) NO308951B1 (ja)
NZ (1) NZ241029A (ja)
PT (1) PT99850B (ja)
SK (2) SK282361B6 (ja)
TW (1) TW227004B (ja)
YU (1) YU189891A (ja)
ZA (1) ZA919938B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59209745D1 (de) * 1991-11-29 1999-10-21 Hoechst Ag Peptide mit insulinartiger Wirkung
SE0002716L (sv) * 2000-07-18 2002-01-19 Lars Wahlberg Komposition mot insekter
WO2002055290A1 (fr) * 2001-01-15 2002-07-18 Societe De Technologie Michelin Tambour de conformation pour la fabrication de pneumatiques
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
KR101909052B1 (ko) * 2017-02-09 2018-10-17 강원대학교산학협력단 인슐린의 a 사슬로부터 유래된 펩타이드 단편 및 이를 포함하는 당뇨병 또는 당뇨병성 창상의 예방 또는 치료용 약학 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2740406A1 (de) * 1977-09-08 1979-03-22 Hoechst Ag Teilgeschuetzte human-insulin-a-kette und verfahren zu ihrer herstellung
DE2801175A1 (de) * 1978-01-12 1979-07-19 Hoechst Ag Verfahren zur herstellung cysteinhaltiger peptide
DD147942A1 (de) * 1979-08-20 1981-04-29 Guenter Losse Verfahren zur herstellung von cystin-peptiden mit insulinaehnlicher wirkung
FR2525592B1 (ja) * 1982-04-26 1984-09-14 Pasteur Institut

Also Published As

Publication number Publication date
HU222493B1 (hu) 2003-07-28
JPH04295496A (ja) 1992-10-20
FI915933A0 (fi) 1991-12-17
DE59109109D1 (de) 1999-04-22
SK282360B6 (sk) 2002-01-07
IL100400A0 (en) 1992-09-06
CA2058020A1 (en) 1992-06-20
JP2003176237A (ja) 2003-06-24
JP3378588B2 (ja) 2003-02-17
CA2058020C (en) 2003-10-28
EP0491361B1 (de) 1999-03-17
EP0491361A3 (en) 1993-11-24
DK0491361T3 (da) 1999-10-11
HUT59697A (en) 1992-06-29
YU189891A (sh) 1995-10-03
HRP940839A2 (en) 1997-06-30
US5461035A (en) 1995-10-24
HU914009D0 (en) 1992-03-30
ZA919938B (en) 1992-09-30
NO308951B1 (no) 2000-11-20
CS387991A3 (en) 1992-07-15
FI105816B (fi) 2000-10-13
ATE177753T1 (de) 1999-04-15
ES2130130T3 (es) 1999-07-01
PT99850A (pt) 1992-11-30
KR920012115A (ko) 1992-07-25
GR3030510T3 (en) 1999-10-29
NO914999L (no) 1992-06-22
FI915933A (fi) 1992-06-20
IE914408A1 (en) 1992-07-01
JP3802863B2 (ja) 2006-07-26
NO914999D0 (no) 1991-12-18
AU8982591A (en) 1992-06-25
KR100237948B1 (ko) 2000-01-15
IL100400A (en) 1998-01-04
NZ241029A (en) 1993-01-27
CZ284568B6 (cs) 1999-01-13
PT99850B (pt) 1999-06-30
EP0491361A2 (de) 1992-06-24
TW227004B (ja) 1994-07-21
HRP940839B1 (en) 2000-02-29
AU643349B2 (en) 1993-11-11

Similar Documents

Publication Publication Date Title
US7157555B1 (en) Exendin agonist compounds
CA2337971C (en) Novel anti-diabetic peptides
FI79854B (fi) Foerfarande foer framstaellning av ett laekemedelspreparat som innehaoller ett insulinderivat.
US7220721B1 (en) Exendin agonist peptides
CN103732617A (zh) 用于胰岛素抵抗的改进的肽医药
IL101452A (en) Analogs of the factor that releases the growth hormone, their preparation and the pharmaceutical preparations that contain them
NZ502592A (en) Exendin agonist peptides and their use in the treatment of type I and II diabetes
EP0544466A1 (en) Tri-arginine insulins
CN108892709A (zh) 改良的肽药物
IE59240B1 (en) Growth hormone releasing factor analogs and processing therefor
CZ281507B6 (cs) Syntetické peptidy, biologický aktivní fragment a jejich netoxické soli
CN112876552A (zh) 长效肾上腺髓质素衍生物
JP3131215B2 (ja) 新規インスリン誘導体
CA1185180A (en) Peptides as medicament and certain novel peptides
EP0734396B1 (en) ANALOGUES OF hGH-RH (1-29)NH2 HAVING ANTAGONISTIC ACTIVITY
US4734399A (en) Growth hormone releasing factor analogs
SK282361B6 (sk) Farmaceutický prostriedok na diabetes mellitus
US5622934A (en) Peptides with an insulin-like action
FI79716C (fi) Daeggdjur-pgrf.
RU2119800C1 (ru) Аналог пептида фактора гормона роста (фгр), способ стимулирования секреции гормона роста и композиция для стимулирования секреции
MXPA00001419A (en) Novel exendin agonist compounds

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20111218